<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04707781</url>
  </required_header>
  <id_info>
    <org_study_id>33-023 ex 20/21</org_study_id>
    <nct_id>NCT04707781</nct_id>
  </id_info>
  <brief_title>Database for Interstitial Lung Disease</brief_title>
  <official_title>Clinical Database for the Early Recognition of Pulmonary Parenchymal Involvement in Patients With Systemic Diseases Bearing a Risk for Interstitial Lung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to establish a clinical database for patients bearing at risk&#xD;
      for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for&#xD;
      these patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>DLCO%pred (carbon monoxide diffusing capacity) at time of ILD diagnosis</measure>
    <time_frame>5 years</time_frame>
    <description>The investigators aim to assess DLCO% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the DLCO%pred at time of ILD diagnosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>FVC%pred (Forced vital capacity) at time of ILD diagnosis</measure>
    <time_frame>5 years</time_frame>
    <description>The investigators aim to assess FVC% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the FVC%pred at time of ILD diagnosis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">412</enrollment>
  <condition>Lung Diseases, Interstitial</condition>
  <arm_group>
    <arm_group_label>prospective patient cohort</arm_group_label>
    <description>patients who will undergo the prospective ILD Screening algorithm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>retrospective patient cohort</arm_group_label>
    <description>patients with diagnosed ILD</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>chest CT</intervention_name>
    <description>assessment of interstitial lung disease using chest CT</description>
    <arm_group_label>prospective patient cohort</arm_group_label>
    <arm_group_label>retrospective patient cohort</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum samples of prospectively included patients will be stored in the Biobank Graz&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients (females and males; above 18 yrs) with a known systemic disease bearing a risk for&#xD;
        ILD but without diagnosed ILD and patients (females and males; above 18 yrs) with diagnosed&#xD;
        ILD.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: â‰¥ 18 years&#xD;
&#xD;
          -  patients with a known systemic disease bearing a risk for ILD&#xD;
&#xD;
          -  signed informed consent (for prospective part)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
&#xD;
          -  comorbidities severely limiting life-expectancy (e.g. severe cardiovascular&#xD;
             conditions, malignant disease)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gabor Kovacs, MD</last_name>
    <phone>+43-316-385</phone>
    <phone_ext>12183</phone_ext>
    <email>gabor.kovacs@klinikum-graz.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Graz, Department of Internal Medicine, Division of Pulmonology</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabor Kovacs, MD</last_name>
      <phone>+43-316-385-80748</phone>
      <email>gabor.kovacs@klinikum-graz.at</email>
    </contact>
    <contact_backup>
      <last_name>Katarina Zeder, MD</last_name>
      <email>katarina.zeder@medunigraz.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 12, 2021</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

